Jump to content
RemedySpot.com

New Study Upends Thinking About How Liver Disease Develops

Rate this topic


Recommended Posts

Posted

http://www.sciencedaily.com/releases/2010/12/101220150936.htm

New Study Upends Thinking About How Liver Disease Develops

ScienceDaily (Dec. 28, 2010) — In the latest of a series of related papers,

researchers at the University of California, San Diego School of Medicine, with

colleagues in Austria and elsewhere, present a new and more definitive

explanation of how fibrotic cells form, multiply and eventually destroy the

human liver, resulting in cirrhosis. In doing so, the findings upend the

standing of a long-presumed marker for multiple fibrotic diseases and reveal the

existence of a previously unknown kind of inflammatory white blood cell.

The results are published in the early online edition of the Proceedings of the

National Academy of Sciences.

In all types of chronic diseases, healthy, functioning tissues are progressively

replaced by fibrous scarring, which renders the tissues or larger organ

increasingly dysfunctional until, eventually, it fails. The process is called

fibrosis. In the human liver, the end result is cirrhosis, the 12th leading

cause of death by disease in the United States with roughly 27,000 deaths

annually. Fibrosis occurs in other organs as well, such as the heart, kidneys

and lungs, with comparable deadly effect.

Scientists do not fully understand the process of fibrosis, particularly how

problematic fibroblast cells are created. For years, conventional wisdom has

posited that fibroblasts are likely to be transformed epithelial cells, a

conversion called " epithelial to mesenchymal transition " or EMT. A protein

called fibroblast-specific protein 1 (FSP1) has long been considered to be a

reliable indicator of fibroblasts in injured organs undergoing tissue remodeling

and has been broadly used to identify the presence of fibrotic disease.

The new research undermines the validity of prevailing assumptions about EMT and

FSP1, but also opens the door to new avenues of investigation that could

ultimately lead to improved detection and treatment of cirrhosis and similar

conditions.

" This work, along with earlier papers, puts into question a whole area of

research -- at least in terms of the liver " said Brenner, MD, Vice

Chancellor for Health Sciences, dean of the UC San Diego School of Medicine and

co-author of the paper. " The old evidence and assumptions about the source of

fibroblasts and the role of FSP1 as a marker are not valid. "

Specifically, in experiments using cell cultures, human liver samples and mouse

models, the researchers found no evidence of EMT -- that transformed epithelial

cells became liver fibroblasts. Rather, endogenous stellate cells appear to be

the culprit, though the scientists note many types of cells seem to contribute,

directly or indirectly, to liver fibrosis.

Likewise, experiments proved FSP1 to be an unreliable marker for fibrosis. Cells

containing FSP1 increased in human and experimental liver disease and in liver

cancer, but researchers found that liver fibroblasts do not express the protein,

nor do hepatic stellate cells -- a major cell type involved in liver fibrosis.

Similarly, FSP1 was determined not to be a marker for myofibroblasts (a

fibroblast with some properties of a smooth muscle cell) or any precursors of

myofibroblasts.

" There have been hundreds of papers based on FSP1 as a marker, " said Brenner.

" That thinking now seems to have been a mistake. One of the take-home messages

of this paper is that FSP1 clearly can't be reliably used as a marker. "

On the other hand, the scientists discovered that FSP1 is a consistent marker

for a previously unknown subset of inflammatory white blood cells or macrophages

found in injured livers. The protein appears to also perform biological

functions in the macrophages, though these remain to be determined.

" It's a whole new class of monocytes, " said Brenner. " We don't know what they

do, but they're worth investigating. "

Co-authors of the study are Christoph H. Osterreicher of the Department of

Medicine, Laboratory of Gene Regulation and Signal Transduction and Department

of Pharmacology, all at UC San Diego, and of the Institute of Pharmacology,

Center for Physiology and Pharmacology and the Department of Internal Medicine,

Division of Gastroenterology at Medical University of Vienna in Austria; Melitta

Penz-Osterreicher of the Department of Medicine at UC San Diego and the

Department of Internal Medicine III, Division of Gastroenterology and

Hepatology, Medical University of Vienna; Sergei I. Grivennikov and Guma

of the Laboratory of Gene Regulation and Signal Transduction, Department of

Pharmacology, UC San Diego; Ekaterina K. Koltsova of the Division of

Inflammation Biology, La Jolla Institute for Allergy and Immunology; Christian

Datz of the Department of Internal Medicine, General Hospital Oberndorf in

Austria; Roman Sasik and Hardiman of Biomedical Genomics Microarray

Facility, Department of Medicine, UC San Diego; and Karin of the

Laboratory of Gene Regulation and Signal Transduction, Department of

Pharmacology at UC San Diego.

Email or share this story:| More

--------------------------------------------------------------------------------

Story Source:

The above story is reprinted (with editorial adaptations by ScienceDaily staff)

from materials provided by University of California - San Diego, via

EurekAlert!, a service of AAAS.

--------------------------------------------------------------------------------

Journal Reference:

1.Christoph H. Österreicher, Melitta Penz-Österreicher, Sergei I. Grivennikov,

Guma, Ekaterina K. Koltsova, Christian Datz, Roman Sasik, Hardiman,

Karin, and A. Brenner. Fibroblast-specific protein 1 identifies an

inflammatory subpopulation of macrophages in the liver. Proceedings of the

National Academy of Sciences, 2010; DOI: 10.1073/pnas.1017547108

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...